Sato Shoji Corporation (TYO:8065)

Intra-Cellular Therapies Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	4,716	3,912	3,175	3,346	2,935	2,427
Cash & Short-Term Investments	4,716	3,912	3,175	3,346	2,935	2,427
Cash Growth	14.88%	23.21%	-5.11%	14.00%	20.93%	23.45%
Receivables	81,248	84,908	91,201	88,952	80,168	62,625
Inventory	29,626	29,453	28,956	30,349	28,167	15,978
Other Current Assets	7,278	7,323	4,935	5,467	6,583	1,681
Total Current Assets	122,868	125,596	128,267	128,114	117,853	82,711
Property, Plant & Equipment	25,391	24,587	21,661	17,679	16,254	16,828
Long-Term Investments	17,246	20,655	22,665	17,695	17,743	16,132
Other Intangible Assets	192	208	186	177	162	180
Long-Term Deferred Tax Assets	103	96	90	76	77	64
Other Long-Term Assets	2,758	1	1	2	1	1
Total Assets	168,558	171,143	172,870	163,743	152,090	115,916
Accounts Payable	48,718	58,742	68,305	65,314	60,735	45,203
Accrued Expenses	780	1,903	1,489	1,669	1,679	1,140
Short-Term Debt	24,506	26,061	18,165	20,253	21,981	6,730
Current Income Taxes Payable	1,121	1,537	1,147	1,456	1,467	774
Other Current Liabilities	13,562	4,014	3,022	3,235	2,233	2,664
Total Current Liabilities	90,584	92,257	92,128	91,927	88,095	56,511
Long-Term Debt	5,219	6,141	10,657	12,546	9,999	8,818
Long-Term Deferred Tax Liabilities	3,436	3,767	4,311	2,603	2,509	2,399
Other Long-Term Liabilities	247	248	343	340	354	375
Total Liabilities	99,726	102,690	107,669	107,642	101,158	68,283
Common Stock	1,321	1,321	1,321	1,321	1,321	1,321
Additional Paid-In Capital	695	732	818	838	862	867
Retained Earnings	57,222	56,376	51,919	46,915	42,072	39,234
Treasury Stock	-914	-1,006	-872	-760	-740	-262
Comprehensive Income & Other	10,491	11,013	12,001	7,776	7,409	6,466
Total Common Equity	68,815	68,436	65,187	56,090	50,924	47,626
Minority Interest	17	17	14	11	8	7
Shareholders' Equity	68,832	68,453	65,201	56,101	50,932	47,633
Total Liabilities & Equity	168,558	171,143	172,870	163,743	152,090	115,916
Total Debt	29,725	32,202	28,822	32,799	31,980	15,548
Net Cash (Debt)	-25,009	-28,290	-25,647	-29,453	-29,045	-13,121
Net Cash Per Share	-1187.51	-1322.40	-1187.42	-1361.74	-1337.55	-597.25
Filing Date Shares Outstanding	21.06	20.99	21.03	21.07	21.07	21.13
Total Common Shares Outstanding	21.06	20.99	21.03	21.07	21.07	21.49
Working Capital	32,284	33,339	36,139	36,187	29,758	26,200
Book Value Per Share	3267.57	3261.04	3099.08	2661.68	2417.36	2216.51
Tangible Book Value	68,623	68,228	65,001	55,913	50,762	47,446
Tangible Book Value Per Share	3258.46	3251.12	3090.24	2653.28	2409.67	2208.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.